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Background: Type 2 diabetes is associated with abnormal electrical conduction and sudden cardiac death, but the
pathogenic mechanism remains unknown. This study describes electrophysiological alterations in a diet-induced
pre-diabetic rat model and examines the underlying mechanism.
Methods: Sprague–Dawley rats were fed either high-fat diet and fructose water or normal chow and water for
6 weeks. The electrophysiological properties of the whole heart was analyzed by in vivo surface ECG recordings, as
wells as ex vivo in Langendorff perfused hearts during baseline, ischemia and re-perfussion. Conduction velocity was
examined in isolated tissue strips. Ion channel and gap junction conductances were analyzed by patch-clamp
studies in isolated cardiomyocytes. Fibrosis was examined by Masson’s Trichrome staining and thin-layer
chromatography was used to analyze cardiac lipid content. Connexin43 (Cx43) expression and distribution was
examined by western blotting and immunofluorescence respectively.
Results: Following 6 weeks of feeding, fructose-fat fed rats (FFFRs) showed QRS prolongation compared to controls
(16.1 ± 0.51 (n = 6) vs. 14.7 ± 0.32 ms (n = 4), p < 0.05). Conduction velocity was slowed in FFFRs vs. controls (0.62 ±
0.02 (n = 13) vs. 0.79 ± 0.06 m/s (n = 11), p < 0.05) and Langendorff perfused FFFR hearts were more prone to
ventricular fibrillation during reperfusion following ischemia (p < 0.05). The patch-clamp studies revealed no
changes in Na+ or K+ currents, cell capacitance or gap junctional coupling. Cx43 expression was also unaltered in
FFFRs, but immunofluorescence demonstrated an increased fraction of Cx43 localized at the intercalated discs in
FFFRs compared to controls (78 ± 3.3 (n = 5) vs. 60 ± 4.2 % (n = 6), p < 0.01). No fibrosis was detected but FFFRs
showed a significant increase in cardiac triglyceride content (1.93 ± 0.19 (n = 12) vs. 0.77 ± 0.13 nmol/mg (n = 12),
p < 0.0001).
Conclusion: Six weeks on a high fructose-fat diet cause electrophysiological changes, which leads to QRS
prolongation, decreased conduction velocity and increased arrhythmogenesis during reperfusion. These alterations
are not explained by altered gap junctional coupling, Na+, or K+ currents, differences in cell size or fibrosis.
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Metabolic disorders such as type 2 diabetes and metabolic
syndrome are associated with abnormal electrical conduc-
tion in the heart, increased risk of cardiac arrhythmias, and
sudden cardiac death [1–3]. The underlying pathophysi-
ology, however, remains to be fully elucidated. Early on, an
abnormal cardiac tissue composition, such as non-
homogenous interstitial fibrosis, was identified as a poten-
tial cause of enhanced susceptibility to arrhythmias in dia-
betes [4]. Subsequently, studies in streptozotocin (STZ)
induced type 1 diabetic rats, revealed decreased conduction
velocity in the heart at baseline, along with a decreased
conduction reserve in response to uncoupling [5, 6]. In the
ventricles, conduction velocity and conduction reserve are
determined by the excitability of individual cardiomyocytes,
intercellular electrical coupling through gap junctions, as
well as obstacles to the propagation of action potentials
such as fibrosis. For STZ induced diabetic rats, gap junction
remodeling, seen as altered expression of the major ven-
tricular gap junction protein connexin43 (Cx43) [7, 8], and/
or Cx43 lateralization [6, 9] are proposed as a potential
mechanism for their altered conduction.
In the setting of insulin resistance and type 2 diabetes,
rats fed a high fat diet (HFD) for 15 weeks display in-
creased infarct sizes along with an increased mortality
rate following ischemia-reperfusion [10]. These findings
were correlated with minor but non-significant changes
in Cx43 phosphorylation. In addition, our laboratory has
recently shown that myocardial impulse propagation is
impaired in Zucker Diabetic Fatty (ZDF) rats (a genetic
model of type 2 diabetes) [11]. In the ZDF rat, we de-
tected a minor degree of Cx43 lateralization, but it
seems insufficient to explain the observed conduction
impairment. Therefore, we hypothesize that other mech-
anisms are involved in the development of conduction
slowing in the diabetic heart. The amount of available
data on this topic is, however, limited and further studies
are needed to identify the complex mechanism of elec-
trical instability in patients with metabolic disorders.
We have previously validated fructose-fat fed rats (FFFRs)
as a useful diet-induced model of metabolic syndrome [12].
Rats fed a high fructose diet is known to develop a higher
degree of hyperinsulinemia and glucose intolerance com-
pared to high fat fed (HFF) rats [13], in contrast, the HFF
rats become more obese. Combining the two diets gives a
model that develops a combination of obesity, hypertriglyc-
eridemia, and severe glucose intolerance, which makes the
FFFR model similar to the phenotype of metabolic syn-
drome seen in humans [12]. After just 6 weeks of feeding,
the FFFRs display increased fasting blood glucose and a sig-
nificantly impaired glucose tolerance [12]. This makes the
FFFR a pre-diabetic model at 6 weeks of feeding. Intramyo-
cardial lipid accumulation is extensive at 6 weeks of high-
fructose-fat feeding, but cardiac hemodynamics remainuncompromised during unstressed conditions for up to
56 weeks of feeding [12]. Nevertheless, FFFRs develop car-
diac hypertrophy within 18 weeks of feeding, as well as an
increased vulnerability to ischemia-reperfusion following
56 weeks on the fructose-fat diet [12]. This study describes
electrophysiological alterations in the hearts of FFFRs and
aims at identifying the underlying cellular mechanisms. In
order to avoid interactions from long-term diabetic compli-
cations, the FFFR hearts were evaluated in the early pre-
diabetic state following 6 weeks of feeding.
Methods
Animal model
Animal studies were performed according to the Guide for
the Care and Use of Laboratory Animals, published by the
US National Institutes of Health (NIH publication No. 85–
23, revised 1996) and approved by the Animal Experiments
Inspectorate of the Danish Ministry of Justice. Four-week-
old male Sprague–Dawley rats (Taconic, Ll. Skensved,
Denmark) were randomly stratified into two groups. One
group (controls) received unlimited normal chow (13 kcal %
fat, Altromin 1319, Brogaarden, Lynge, Denmark) and
water, and the other group, fructose-fat fed rats (FFFR), re-
ceived unlimited high-fat diet (60 kcal % saturated fat,
D12492, Research Diets, New Brunswick, USA) and 10 %
fructose (F0127, Sigma-Aldrich, Brøndby, Denmark) in the
drinking water as previously described [12]. To avoid bac-
terial growth in the drinking water, citric acid was added to
give a pH of 3.6 in both control and fructose water. Rats
were kept on this special diet for 6 weeks before entering
the experiments described below.
Blood samples, fasting glucose and insulin measurements
Rats fasted for 16 h were gently restrained and their
fasting blood glucose was measured on a (~2 μL) tail
blood sample using a FreeStyle Lite analyzer (Abbott,
Copenhagen, Denmark). Subsequently, a sample of
tongue blood (~300 μl) was collected and transferred to
heparin containing micro tubes (VWR, Herlev, Denmark).
The samples were centrifuged at 1500 g for 15 min at 4 °C.
Plasma was collected and stored at −80 °C for later analysis.
Plasma insulin was measured with ELISA (cat no.
EIA2048, DRG International, Marburg, Germany) ac-
cording to the manufactures instructions.
In vivo ECG recordings
Seven needle electrodes were inserted subcutaneously into
lightly anesthetized (1.5 % isoflurane in O2) rats. Four elec-
trodes were connected to the limbs, while the remaining
electrodes were placed precordially. ECG’s were obtained
with an electronic recorder (GE MAC 800, GE Healthcare,
Milwaukee, WI). ECG recordings were transferred to a cen-
tral database (GE Muse Cardiology Information System,
GE Healthcare, Milwaukee, WI) and analyzed manually in
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included P-wave duration and amplitude, QRS-complex
duration and amplitude as well as QT-interval and cor-
rected QT-interval (QTc) using formulas proposed by
Bazett and Kmecova [14]. The QRS width was measured
from the beginning of the Q-wave to the negative peak of
the S-wave. QT was measured from the beginning of the
Q-wave to the point where the downslope of R’ return to
the isoelectric line.
Conduction velocity and contractility of ventricular strips
Conduction velocity and contractility was measured in tis-
sue strips from the free wall of the right ventricle as previ-
ously described for atrial tissue [15]. In short, hearts were
explanted from rats anesthetized with 5 % isoflurane in
35 % O2/N2. Tissue strips were mounted in a 1 ml chamber
and perfused with 35 °C, 100 % O2 bubbled Tyrode’s buffer
(mM: 136 NaCl, 4 KCl, 0.8 MgCl2, 1.8 CaCl2, 5 HEPES, 5
MES, 10 Glucose, pH 7.3) at a flow rate of 2 ml/min. The
tissue was paced with a unipolar stimulation electrode at
1 Hz, impulse duration 0.5 ms and double threshold voltage
(Master-8 stimulator, A.M.P.I., Jerusalem, Israel). Conduc-
tion velocity was measured using two extracellular micro-
electrodes (Platinium/Iridium (PI20030.5B10), Micro Probe
Inc., Gaithersburg, USA) placed on the longitudinal axis of
the tissue strip. Time of local activation under the first and
second microelectrode was determined as the time of mini-
mum dU/dt by custom written MatLab script. Conduction
velocity was calculated as the inter-electrode distance di-
vided by the inter-electrode delay. Force was recorded con-
tinuously using the isometric force-transducer. Muscle
length was adjusted to the level where contractions under
control conditions were 50 % of maximal. Following a
15 min resting period, conduction velocity was measured
over a 20 min period and developed force and passive ten-
sion were analyzed and calculated by the custom written
MatLab script.
Ischemia-reperfusion study
Rats were anaesthetized with 5 % isoflurane in 35 % O2/N2
and the aorta was cannulated as previously described [16].
The hearts were transferred to a perfusion apparatus (Hugo
Sachs Elektronik – Harvard Appartus GmbH, March-
Hugstetten, Germany) and perfused in the Langendorff
mode with modified Krebs-Henseleit solution (mM: 118
NaCl, 4.7 KCl, 1.75 CaCl2, 1.2 KH2PO4, 1.2 Mg2SO4, 24.9
NaHCO3, 11.0 glucose) under continuously bubbling with
carbogen (95 % O2/5 % CO2) and a constant perfusion
pressure of 80 mmHg. A fluid filled balloon (size 5) (Hugo
Sachs Elektronik – Harvard Appartus GmbH, March-
Hugstetten, Germany) was inserted through an incision in
the left auricle into the left ventricle to allow measurements
of left ventricular pressure (LVP). The volume of the bal-
loon was adjusted to give an end-diastolic pressure ofapproximately 5 mmHg. Subsequently, a ligature was
placed around the left anterior descending coronary artery
(LAD), enabling induction of ischemia. The experiment
progressed as 30 min of normal perfusion (baseline),
30 min of LAD occlusion, and 60 min of re-perfusion.
Langendorff studies were recorded and evaluated using
iox2 version 2.4.2.6 software (emka TECHNOLOGIES,
Paris, France).
Area at risk and infarct size
At the end of Langendorff experiments the LAD ligature
was re-clamped and the heart perfused with Evans Blue dye
(0.1 %) (SIGMA, E2129) to evaluate the area at risk of in-
farction. Subsequently, the heart was sliced into ~2 mm
thick vertical slices and incubated in 2,3,5-triphenyltetrazo-
liumchloride (TTC, SIGMA T8877) 10 mg/ml in 0.1 M
phosphate buffer (pH 7.4) for 10 min at 37 °C. Subse-
quently, the tissue slices were washed 3 times in MilliQ
water and transferred to 4 % formalin overnight. Finally,
the tissue slices were weighed and scanned on both sides at
1200 DPI to analyze the infarct size. Pictures were analyzed
in a blinded fashion using ImageJ software.
Arrhythmia analysis
ECG recordings during Langendorff experiments were
obtained using a 6-lead Einthoven ECG recording system
(Hugo Sachs Elektronik – Harvard Apparatus GmbH,
March-Hugstetten, Germany) and analyzed using
ecgAUTO v2.8.1.26 software (emka TECHNOLOGIES,
Paris, France). In short, individual ECG libraries were
generated for each experiment. QRS and QT duration
were analyzed and the number of extra systoles (also
known as a ventricular premature complex), as well as
the number, morphology and duration of each episode
of arrhythmia determined. In general, the arrhythmia
analysis complies with the updated Lambeth conven-
tions [17]. Episodes of VT were defined as at least 4
consecutive ventricular complexes, however, we did not
distinguish between monomorphic, polymorphic, or
Torsades de pointes VTs. VF was defined as a continu-
ous entry for which individual QRS complexes could
no longer be distinguished from each other. In regard
to QT duration, the end of the T-wave was set as the
point where the downslope returned to the isoelectric
line.
Isolation of cardiomyocytes
Rats were anesthetized by 5 % isoflurane in 35 % O2/N2
and the heart perfused in a custom made perfusion system
at a constant pressure of 60 mmHg. The heart was perfused
with Tyrode’s solution (mM: 136 NaCl, 4 KCl, 5 HEPES, 5
MES, 0.8 MgCl2, 1.8 CaCl2, 10 glucose, pH 7.4) for 5 min
followed by 2 min perfusion with Ca2+ free Tyrode’s solu-
tion and 2 min with potassium-gluconate buffer (mM: 20
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glucose, pH 7.4). Subsequently, the heart was perfused with
potassium-gluconate buffer including collagenase (140–165
U/ml) (Type 2 from Worthington) until the heart was
digested (approximately 20–25 min). The ventricles were
then sliced into small pieces, placed in collagenase buffer
and bubbled with 100 % O2 till the tissue was dissolved.
The solution was filtered and left to settle for 10 min. Car-
diomyocytes used for measurements of gap junction con-
ductivity was gradually added Ca2+ to give a final
concentration of 0.75 mM.
Gap junction coupling
Intercellular coupling was measured in ventricular cell pairs
at room temperature using the dual whole-cell patch-clamp
method as previously described [18]. Cells were voltage
clamped at −10 mV, and a 1 s −10 mV pulse was applied to
one cell at 0.1 Hz. Data was analyzed using Cellworks
Reader (NPI Electronic). The average intercellular conduct-
ance during a 90 s interval following patch break was calcu-
lated as the resulting current deflection in the passive cell
(nonpulsed) divided by the transjunctional voltage differ-
ence using a custom-made MatLab script.
Na+-channel activity
Whole-cell sodium currents (INa) were recorded at room
temperature on ventricular myocytes. The internal solution
consisted of 5 mM NaCl, 135 mM CsF, 10 mM EGTA,
5 mM MgATP and 5 mM HEPES (pH 7.2 with CsOH) and
the low-sodium external solution consisted of 20 mM
NaCl, 1 mM CaCl2, 1 mM MgCl2, 0.1 mM CdCl2, 20 mM
HEPES, 117.5 mM CsCl and 11 mM glucose (pH 7.4 with
CsOH). To characterize the voltage dependence of the peak
sodium current, single myocytes were held at −120 mV,
and 200 ms voltage steps were applied from −80 to
+15 mV in 5 mV increments. Interval between each steps
was 3 s. Measurements were made with pClamp10 software
and a MultiClamp 700B amplifier sampling at 20 kHz and
filtering at 5 kHz (Molecular Devices, Axon Instruments,
Sunnyvale, USA). Borosilicate glass pipettes were pulled on
a DPZ-Universal puller (Zeitz Instruments, Martinsried,
Germany). The pipettes had a resistance of 1.5–2.5 MΩ
when filled with intracellular solution. The series resistance
recorded in the whole-cell configuration was 2–5 MΩ and
was compensated (80 %).
K-channel activity
K+-channel voltage-clamp recordings were made using
an EPC7 amplifier (HEKA Elektronik, Lambrecht/
Pfalz, Germany) and digitized with a Digidata 1440A
converter (Axon Instruments, Molecular Devices,
Sunnyvale, California). pClamp10 software was used for
data acquisition (Axon Instruments, Molecular Devices,
Sunnyvale, California). Patch pipettes were fabricated fromborosilicate glass capillaries (GC150F, Harvard Apparatus,
Edenbridge, UK) using a gravity puller PIP5 puller (HEKA,
Lambrecht/Pfalz, Germany) and the pipette resistance
ranged from 1 to 3 MΩ. The cardiomyocytes were super-
fused with a HEPES buffer (mM: 126 NaCl, 5.4 KCl, 1.0
MgCl2, 2.0 CaCl2, 10 HEPES and 11 glucose, pH adjusted
to 7.4 with NaOH and 300 μM Cd to block ICaL). The
patch pipette solution had the following composition (in
mM): 90 K-aspartate, 30 KCl, 5.5 glucose, 1.0 MgCl2, 5
EGTA, 5 MgATP, 5 HEPES, 10 NaCl, pH 7.2 with KOH.
The experiments were performed at 37 °C. After a whole-
cell patch was established, cell capacitance was measured
by applying −5 mV voltage steps. From a holding potential
of −80 mV, sodium currents were inactivated by a 10 ms
step to −40 mV and potassium currents were activated by
a step protocol ranging from −120 to 40 mV for 2 s. A
voltage–current relationship of the initial part of the step
protocol is shown. Compensation of series resistance to
60–70 % was applied to minimize voltage errors. All ana-
log signals were acquired at 10–50 kHz and filtered at 4–
6 kHz. All electrophysiological experiments were blinded
during acquisition and data analysis.
Plasma and cardiac lipid measurements
Enzymatic kits were used for measurements of free fatty
acids (Wako NEFA C kit, TriChem Aps, Frederikssund,
Denmark), cholesterol (CHOD-PAP; Roche Applied Sci-
ence), and free glycerol and triglycerides (TR0100, serum
triglyceride determination kit, Sigma) in plasma samples.
Cardiac lipid content was measured by thin-layer chro-
matography (TLC) as previously described [19]. All sam-
ples were analyzed in duplicate on separate TLC plates
and quantified by digital image analysis using the ImageJ
software.
Fixation of hearts for fibrosis and Cx43 staining
Rats were anaesthetized by 5 % isoflurane in 35 % O2/N2
and the hearts removed, cannulated and connected to a
homemade perfusion system as described for isolation of
cardiomyocytes. The hearts were perfused at 60 mmHg
with modified Krebs-Henseleit solution for 2 min
followed by 10 ml of 2 % paraformaldehyde (PFA) dis-
solved in PBS pH 7.2. The hearts were immersed in 2 %
PFA solution and stored at 4 °C overnight. The fixed
hearts were subsequently stored in 0.5 % PFA at 4 °C
until staining.
Immunofluorescence
Fixated hearts were coated in paraffin and cut in 12 μm
thick slices. Slices of right ventricular tissue were deparaffi-
nized, permeabilized and incubated with the primary anti-
bodies anti-Cx43 (C6219, Sigma-Aldrich, St. Louis, MO,
1:1000) and anti- N-cadherin (C3865 Sigma-Aldrich, St.
Louis, MO, 1:500) and the appropriate secondary ALEXA
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previously described [11]. Slices were imaged using a laser
confocal microscope (Zeiss LSM 780, Carl Zeiss, Jena,
Germany) and a 63x Oil, NA 1.4 objective.
Amounts of total Cx43 and Cx43 not localized within
3 μm of N-Cadherin (regarded as Cx43 not localized in
intercalated discs), were analyzed in a blinded fashion.
Histomorphometric analysis
Sections of fixed ventricular tissue were in coated in par-
affin and processed for Masson’s Trichrome staining and
histological examination as previously described [11].
The analysis was made in a blinded fashion.
Western blotting
Hearts were explanted from isoflurane anesthetized rats
and homogenized as previously described [20]. Ten per-
cent Bis-Tris gels and MOPS running buffer were used
and the proteins were blotted onto nitrocellulose mem-
branes (all from Life technologies, Nærum, Denmark).
Anti-Cx43 (C6219) 1:50.000, anti-β-tubulin (T0198)
1:2000 (both from Sigma-Aldrich, Brøndby, Denmark),
anti-mouse (IRdye680RD) 1:10.000, and anti-rabbit
(IRdye800CW) 1:10.000 (LI-COR Biosciences, Cambridge,
UK) were used and membranes analyzed using Odyssey
CLx Infrared Imaging System (LI-COR Biosciences,
Cambridge, UK).
Statistical analysis
All data are presented as mean ± standard error of the
mean (SEM). Statistical analysis was performed using
GraphPad Prism 5 (GraphPad Software,Inc. La Jolla,
CA) or SAS 9.2 (SAS Institute, Cary, NC). For single pa-
rameters, differences between groups were generally an-
alyzed using an unpaired Students t-test. For a subgroup
of data sets, variances were significantly different be-
tween groups. In these cases, an unpaired t-test with
Welch’s correction was performed. The ECG and
Langendorff data were analyzed using mixed models
with repeated measures in PROC MIXED, followed by
Duncan’s new multiple range test. p < 0.05 was consid-
ered statistically significant.
Results
General characteristics of FFFR and control rats
During 6 weeks of feeding, FFFRs developed increased
body mass compared to control fed rats, whereas there
heart weight remained unaffected (Table 1). In addition,
FFFRs increased their fasting blood glucose and insulin
levels. The plasma triglyceride level was also increased
and the cardiac triglyceride content was 2.5 times higher
in FFFRs compared to control fed rats (Table 1). Besides
the increase in insulin levels, these general characteris-
tics of FFFRs are consistent with what we havepreviously published [12]. In our previous study, however,
hyperinsulinemia was not significant at 6 weeks of feeding,
but presented between 6 and 12 weeks of feeding.
FFFRs display QRS prolongation in vivo
In vivo ECG recordings from rats in light isoflurane
anesthesia (Fig. 1) revealed that FFFRs had prolonged
QRS duration compared to control rats (p = 0.017). In
contrast, heart rate, P-wave duration and amplitude (P-
wave data not shown), PQ, and QT intervals were not
significantly different between the two groups (Fig. 1).
QTc-Bazett intervals were 198 ± 27 ms and 184 ± 24 ms in
control and FFFR hearts respectively (p = 0.7) and QTc-
Kmecova [14] intervals were 76.7 ± 11 ms and 71.3 ± 9 ms
respectively (p = 0.7). So in general, no difference was
found in QT or QTc intervals irrespective of the QT cor-
rection formula used.
In addition to the prolonged QRS duration, premature
ventricular complexes (PVCs) in sustained trigeminy
(two sinus beats followed by a PVC) were observed in
one of the six FFFRs (Fig. 1, lower left panel). None of
the control rats showed any spontaneous arrhythmias.
Conduction velocity is decreased in FFFRs
QRS prolongation represents a conductance abnormality,
which may be explained by decreased conductance velocity
in the ventricles. In support of this, measurements of im-
pulse propagation in tissue strips from the right ventricle
revealed a decreased conduction velocity in FFFRs com-
pared to control rats (0.62 ± 0.02 vs 0.79 ± 0.06 m/s, p =
0.02) (Fig. 2). At the same time, developed force (119 ± 15
vs. 155 ± 24 mg/mm2, p = 0.21) and diastolic force (141 ±
22 vs. 202 ± 34 mg/mm2, p = 0.13) were not significantly
different between tissue strips from FFFRs and controls,
respectively.
FFFRs and control rats respond differently to ischemia-
reperfusion
To examine if the observed conductance abnormalities pre-
dispose FFFRs to cardiac arrhythmias, we evaluated both
functional and electrophysiological characteristics of
Langendorff perfused hearts, before, during and following
30 min of LAD occlusion. There were no statistically signifi-
cant differences in either area at risk (27.1 ± 1.4 % and 27.5
± 2.1 %, p = 0.87, for control and FFFR respectively) or in-
farct size (11.5 ± 1.6 % and 10.6 ± 0.92 %, p= 0.66, for con-
trol and FFFR respectively) following ischemia-reperfusion.
As shown in Fig. 3, heart rate (HR) was not signifi-
cantly different between the two groups. There was no
statistically significant interaction term between group
and time for flow, but the flow did change significantly
with time (p < 0.0001). In addition, the flow was slightly
higher in hearts from FFFRs compared to controls
throughout the perfusion period, although the difference
Table 1 General characteristics of fructose-fat fed rats (FFFR) and control rats
FFFR n Control n P-value
Body mass (g) 393 ± 5.9 44 366 ± 4.9 44 <0.001
Heart weight (g) 1.16 ± 0.04 11 1.10 ± 0.06 11 ns
Fasting blood glucose (mM) 4.2 ± 0.10 44 3.8 ± 0.08 44 <0.01
Fasting insulin (pmol/L) 98.8 ± 17 15 35.0 ± 5.9 11 <0.01
Fasting plasma cholesterol (mM) 2.1 ± 0.12 12 2.2 ± 0.08 12 ns
Fasting plasma glycerol (mM) 0.30 ± 0.02 12 0.25 ± 0.03 12 ns
Fasting plasma triglyceride (mM) 1.2 ± 0.15 12 0.72 ± 0.06 12 <0.05a
Fasting plasma FFA (mM) 0.32 ± 0.02 12 0.38 ± 0.03 12 ns
Cardiac cholesterol (nmol/mg ww) 3.3 ± 0.23 12 2.8 ± 0.23 12 ns
Cardiac triglyceride (nmol/mg ww) 1.9 ± 0.19 12 0.77 ± 0.13 12 <0.0001
Data are presented as mean ± SEM
FFA free fatty acids, ww wet weight, NS non-significant
aan unpaired t-test with Welch’s correction was performed, due to significantly different variances in the two groups
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left ventricular pressure (DLVP) was not different between
the two groups at baseline, the FFFR group, however, main-
tained a higher DLVP during ischemia (p < 0.05 between
the two groups and p < 0.05 for the interaction between
group and time). For the maximum increase in pressure
over time during systole (dP/dt max) there was no signifi-
cant interaction term between group and time. dP/dt maxFig. 1 In vivo surface electrocardiogram (ECG) analysis from lightly anesthe
(FFFR) and a FFFR with premature ventricular complexes (PVCs) corresponding
QT interval, as well as QRS duration is shown to the right. In rodents, there is no
repolarization was therefore determined manually, as the point where the slope
ER (end of repolarization) and used as the end of the measured QT interval. The
as mean ± SEM, *p< 0.05did, however, change significantly with time (p < 0.0001)
and it was significantly higher in the FFFRs compared to
controls (p < 0.01). Finally, the maximum decrease in pres-
sure over time during diastole (dP/dt min) showed a signifi-
cant interaction between group and time (p < 0.01) (data
not shown).
For the electrophysiological parameters the mixed
models ANOVA showed no interaction between grouptized rats. Representative recordings from a control, a fructose-fat fed rat
to a trigemini is shown on the left side. The average heart rate (HR), PQ and
clearly demarcated T-wave as seen in larger mammals. The end of the
from R’ (second R-wave) crosses the isoelectric line. This point is marked
data analysis was conducted in a blinded fashion and data are presented
Fig. 2 Ventricular conduction velocity. Conduction velocity was
measured in the longitudinal direction of right ventricular strips from
control and fructose-fat fed rats (FFFR). Data are presented as
mean ± SEM, *p < 0.05
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of ischemia and re-perfusion on QRS length is not sig-
nificant different between control and FFFR hearts.
Though, looking at the entire perfusion period (baseline,
ischemia and re-perfusion) the QRS complex was signifi-
cantly prolonged in FFFRs compared to controls (p <
0.001). In contrast, we did not detect any significant dif-
ferences in QT duration between the two groups andFig. 3 Functional and electrophysiological data for Langendroff perfused h
during baseline, 30 min of left anterior descending coronary artery (LAD) o
left ventricular pressure. dP/dt max: maximum change in pressure over tim
Data are presented as mean ± SEM, * p < 0.05, ** p < 0.001. n = 11 for boththe QT interval was not significantly changed by either
ischemia or re-perfusion. When evaluating the func-
tional and electrophysiological data, it must be noted
that the data only include observations from hearts in
sinus rhythm. During the ischemic period, ten of eleven
control hearts and six of eleven FFFR hearts had epi-
sodes of ventricular tachycardia (VT), whereas all hearts
in both groups developed VT episodes during reperfu-
sion. As seen in Fig. 3, there was a tendency towards the
control hearts being in VT for a longer period of time
than the FFFR hearts, however, it did not reach statisti-
cally significance (p = 0.07). Episodes of non-sustained
ventricular fibrillation (VF) were also observed in both
groups during both ischemia and reperfusion. Sustained
VF was, however, only observed during reperfusion and
occurred in one of eleven control hearts and five of
eleven FFFR hearts. Summarizing episodes of sustained
and non-sustained VF in the reperfusion period, FFFR
hearts were significantly more prone to VF than control
hearts (p < 0.05) (Fig. 3).
Ion currents and gap junction conductance are unaltered
in FFFRs
The observed changes in cardiac conductance may be
caused by changes in ion currents, decreased gap junc-
tion conductance, or altered tissue architecture in the
form of changes in size of the individual cardiomyocytesearts. Data are presented from control and fructose-fat fed rats (FFFR),
cclusion and 60 min of re-perfusion. HR: heart rate. DLVP: developed
e during systole. VT: ventricular tachycardia. VF: ventricular fibrillation.
groups
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voltage-clamp recordings of isolated ventricular cardio-
myocytes to analyze sodium and potassium currents,
gap junction conductance, as well as cell capacitance.
Representative sodium current traces are shown in Fig. 4
along with the measured sodium current parameters.
The peak current density as a function of voltage nor-
malized to cell capacitance was unaltered between the
two groups (Fig. 4b) and so was the steady state inactiva-
tion (V½ = −91.89 ± 2.33 mV vs −91.14 ± 1.09 mV, in
controls and FFFRs respectively) (Fig. 4c) and the
steady-state activation (V½ = −33.24 ± 0.93 mV vs −34.18
± 2.89 mV, in controls and FFFRs respectively) (Fig. 4d).
The late Na + current (INaL) at −40 mV (measured as the
mean current between 150 and 200 ms) also remained
unchanged between the two groups (−2.14 ± 0.17 and
−2.32 ± 0.21 pA/pF in controls and FFFRs respectively)
(data not shown).
Representative potassium current recordings are shown
in Fig. 5a (control) and b (FFFR). The sustained currents
were measured at the end of the protocol and shown as a
function of voltage in Fig. 5c. The inward component rep-
resents the inward rectifier current, IK1 and the outward
current predominantly reflects sustained outward potas-
sium currents, such as ISS, and no significant differences
were observed between control and FFFR cardiomyocytes.
The amplitude of the transient outward potassium currents,Fig. 4 Whole-cell voltage-clamp Na+ current recordings in acutely isolated
following depolarisations from – 80 to 5 mV increments from both control
peak sodium current normalised to cell capacitance. c Steady-state inactiva
sodium current. Data are based on 14 single cell recordings for both group
as mean ± SEMIto, was determined by subtracting the sustained currents
from the peak current as shown in Fig. 5d. To further dis-
sect the currents, steady-state inactivation was addressed as
previously described by Himmel et al. [21]. Fig. 5e shows
normalized currents recorded at the +20 mV tail step on
the protocol shown as an insert in panel A. The voltage
range from approximately −120 to −40 mV has previously
been ascribed to a delayed rectifying current, whereas the
current in the range from −40 to −10 mV has been ascribed
to Ito and the remaining current to a sustained component
such as ISS [21]. Ito can be further divided into a current
with a slow time dependent recovery from inactivation, Ito,s,
and a current component with a fast recovery from inacti-
vation, Ito,f. Ito,f down-regulation has repeatedly been associ-
ated with diseases such as heart failure and diabetic
cardiomyopathy [22, 23] and as the data in Fig. 5d suggests
a tendency toward reduced Ito, we investigated if the contri-
bution from Ito,f and Ito,s were affected in the FFFRs. Cur-
rents were elicited by a two-step protocol as shown in
Fig. 5f and recovered currents were plotted as a function of
interpulse-interval but no significant changes were ob-
served between cardiomyocytes from controls and FFFRs.
Gap junction conductance was examined by dual-clamp
recordings on ventricular cell pairs (Fig. 6a) but no statis-
tical significant change in gap junction conductance was
observed between the two groups (p = 0.33). Finally, cell
capacitance, examined on individual ventricularventricular cardiomyocytes. a Representative sodium current traces
s and fructose-fat fed rats (FFFR). b Current–voltage relationship of the
tion of the transient sodium current. d Steady-state activation of the
s originating from 6 control and 4 FFFR hearts. Data are presented
Fig. 5 Whole-cell voltage-clamp K+ current recordings in acutely isolated ventricular cardiomyocytes. Representative recordings from control (a) and
Fructose-fat fed rat (FFFR) (b) ventricular cardiomyocytes. c Sustained current density measured at the end of the voltage protocol (as indicated by the
black arrow on the inserted protocol) as a function of voltage. (Control cells n= 17, FFFR cells n= 19). d Transient current density determined as the peak
current density (measured at the start of the voltage protocol as indicated by the grey arrow) subtracted sustained current density. Control cells n= 17,
FFFR cells n= 19. e Steady state inactivating control. Currents recorded at the +20 mV were normalized to maximal current, n= 16, FFFR, n= 19. f Time
dependent recovery from inactivation was determined by a two-step protocol with increasing interpulse intervals, control n= 11, FFFR n= 19. Data are
based on cells from 5 FFFR and 6 control hearts and presented as mean ± SEM, *p< 0.05
Fig. 6 Gap junction conduction and cell capacitance. a Gap junction conduction measured by dual-clamp recordings on isolated cardiomyocyte
cell pairs from 5 control and 4 fructose-fat fed rats (FFFR). b Cell capacitance of individual cardiomyocytes. Data are presented as mean ± SEM
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from control and FFFR hearts (Fig. 6b). This indicates that
the sizes of the individual cardiomyocytes are similar be-
tween control and FFFR hearts.
Connexin43 expression and localization
When evaluating the localization of Cx43 by immuno-
histochemistry (Fig. 7a-c), a higher fraction of Cx43 lo-
calized in approximation of N-cadherin was found in
the FFFR group compared to the control group (78.4 ±Fig. 7 Connexin43 (Cx43) localization and expression. Representative immu
(in red, middle column) and an overlay (right column) of Cx43 (green), N-C
from fructose-fat fed rat (FFFR) hearts . The images shown are a maximum
co-localized with N-Cadherin for control (n = 6) and FFFRs (n = 5). d Repres
(C = control and F = FFFR). e Quantification of Cx43 expression (quantificati
as mean ± SEM, ** p < 0.013.28 % (n = 5) vs. 59.6 ± 3.55 % (n = 6), p < 0.01). This
indicates that a higher fraction of Cx43 is localized in
gap junction plaques at the intercalated discs in the
FFFRs compared to the controls. In contrast, we found
that the expression level of the major ventricular gap
junction protein Cx43 was similar between the two
groups, when evaluated by western blotting (Fig. 7d
and e). This is in accordance with the finding that gap
junction conductance was unaffected between the
two groups.nofluorescence images of Cx43 (in green, left column), N-Cadherin
adherin (red) and nuclei (blue). a Images from control hearts. b Images
projection of 4 optical sections of heart tissue. c Quantification of Cx43
entative western blot of Cx43 and β-tubulin expression in cardiac tissue
on was performed in duplicates and n = 4/group). Data are presented
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cardiac fibrosis
As seen in Fig. 8, there were no significant histological
changes in cardiac tissue from either controls or FFFRs.
The fraction of non-cardiomyocytes were 1.38 ± 0.36 %
(n = 6) and 2.01 ± 0.26 % (n = 7), p = 0.17) for control
and FFFR hearts respectively.
Discussion
We have previously validated the FFFR model as a diet-
induced rat model of metabolic syndrome [12]. Our
previous study found no signs of contractile dysfunction
under unstressed conditions in hearts from FFFRs for
up to 48 weeks of feeding, but their hearts were more
prone to asystole during reperfusion after ischemia [12].
This indicated electrical alterations in the heart of
FFFRs. Abnormal electrical propagation, reflected as
prolonged QRS and QT interval, as well as an increased
risk of sudden cardiac death, is well established for type
2 diabetic patients (reviewed in [24]). The pathophysio-
logical mechanism(s), however, are yet to be elucidated.Fig. 8 Cardiac fibrosis analysis. This figure shows representative
images of Masson’s Trichrome stainings of the right ventricle from a
control and a fructose-fat fed rat (FFFR). Masson’s trichrome stainings
were used to show that there is no difference in fibrosis between
the two groupsTherefore, we investigated the electrophysiological charac-
teristics of FFFRs, in the early pre-diabetic state, following
6 weeks of feeding.
In terms of metabolic status, we found that the FFFRs
became overweight, with some hyperglycemia, hyperin-
sulinemia and increased plasma lipid levels, which was
also reflected by increased intramyocardial triglyceride
content. These findings, except for the hyperinsulinemia,
are in agreement with our previous study [12], which
also demonstrated that the FFFR model have a decreased
intra venous glucose tolerance after 6 weeks of feeding.
In our previous study, insulin levels were, however, not
elevated until after 6 weeks of feeding. Nevertheless, to-
gether these data demonstrates that the FFFRs at 6 weeks
of feeding can be characterized as a pre-diabetic model.
In the present study, we show that FFFRs display pro-
longed QRS and unchanged QT and QTc duration
in vivo. An increased prevalence of QTc prolongation
and dispersion is well established in diabetic patients
[25, 26] and QT prolongation is also seen in diet-
induced-obese (DIO) mice kept on a high-fat diet for
12–14 weeks [27]. The reason why we do not detect any
QT changes in the FFFRs may simply be because our
ECGs were recorded in the early pre-diabetic state after
just 6 weeks of feeding; however, our QT data could also
be influenced by the gradual downslope of the T-wave,
which makes it difficult to detect the end of the QT
interval in rodent ECGs. We do, however, detect a sig-
nificant prolongation of the QRS complex in the FFFR
hearts. A widening of the QRS complex is also seen at
the onset of diabetes in ZDF rats [28] and at 2 and
7 months of age in the type 2 diabetic Goto-Kakizaki rat
[29], as well as in type 2 diabetic humans [30]. Pro-
longation of the QRS complex reflects the presence of
intraventricular conductance abnormalities, such as
bundle-branch block, decreased ventricular conduction
velocity and/or ventricular hypertrophy. With respect
to the latter, our data show that heart weight is not signifi-
cantly increased in FFFRs compared to controls after
6 weeks of feeding and we have previously established that
cardiac hypertrophy is not present until 18 weeks of feed-
ing [12]. In the present study, we find that conduction vel-
ocity is significantly slowed in tissue strips from the right
ventricle of FFFRs compared to control rats. We have pre-
viously made the same observation in type 2 diabetic ZDF
rats [11] and a similar reduction in conduction velocity is
also described for STZ induced type 1 diabetic rats [7].
The present study is, however, the first to show conduc-
tion slowing in the heart of a diet-induced animal model.
Conductance disturbances such as decreased conduction
velocity increase the risk of ventricular arrhythmias. In vivo
we made the observation that one of the six FFFRs pre-
sented with PVCs in trigeminy with two sinus beats under
unstressed conditions. In addition, Langendorff perfused
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LAD occlusion compared to hearts from control fed
rats. Hearts from FFFRs preserved a higher contractility
during ischemia, which was seen as a higher DLVP and
dP/dt max, even though the area at risk was similar be-
tween control and FFFR hearts. The increased contract-
ility of FFFR hearts during ischemia is in agreement
with our previous findings in hearts from FFFRs follow-
ing 56 weeks of feeding [12]. In the previous study, we
found that the FFFR group at 56 weeks of feeding was
more prone to develop asystole during re-perfusion,
and the present study shows that this is not the case at
6 weeks of feeding where FFFRs are more prone to VF
during re-perfusion. The increased susceptibility to VF
during reperfusion is not caused by increased infarct size.
The unaffected infarct size is in contrast to earlier studies,
where rats keep on a high-fat diet for 15 weeks [10] or a
sucrose-condensated milk diet for 20 weeks [31] both de-
velops increased infarct sizes after ischemia-reperfusion.
This discrepancy may, however, be explained by the differ-
ent feeding periods and regimes. Therefore, we conclude
that pre-diabetic FFFRs have an increased susceptibility to
ventricular arrhythmias following reperfusion, which is
not explained by changes in infarct size.
In pathophysiological conditions such as cardiac ische-
mia and heart failure, decreased conduction velocity and
increased arrhythmogenicity have been related to altered
gap junction coupling. Compromised gap junction coup-
ling may arise from: 1) decreased expression of the
major ventricular gap junction protein Cx43; 2) closure
or reduced conductance of the gap junction channels
(e.g. by altered phosphorylation state); or 3) loss of gap
junctional channels from the intercalated discs. In STZ
induced type 1 diabetic rats, altered expression, localization
and phosphorylation of Cx43 have all been suggested as the
cause of impaired conduction; however, data are contradic-
ting [6–9, 32]. In the ZDF rat, a decrease in the amount of
Cx43 co-localized with N-cadherin at the intercalated discs
was found [11]. In the present study, we found that the
Cx43 expression was unaltered between controls and
FFFRs and that the fraction of Cx43 co-localized with N-
cadherin was actually increased in the FFFR group. The in-
crease in Cx43 at the intercalated disc did, however, not
translate into an altered gap junction conductance in iso-
lated cardiomyocytes. Despite the lack of evidence for
changes in gap junction coupling in the isolated cells, it
would still be interesting to examine the phosphorylation
state of Cx43 in the intact FFFR heart. However, given the
complex nature of Cx43 phosphorylation (For review see
Axelsen et al. 2013 [33]), it requires an extensive mass
spectrometry based analysis, which is beyond the scope
of this paper. Nevertheless, the lack of changes in gap
junction conductance indicates that although cardiac
gap junction remodeling may be evident in somediabetic models, it is unlikely to be the primary cause of
conduction disturbances and increased arrhythmogen-
esis in the pre-diabetic FFFR model.
Other mechanisms that may contribute to decreased
conduction velocity is a decrease in cardiomyocyte excit-
ability due to altered Na+-channel activity or changes in cell
size. Altered INa density and increased cell capacitance have
previously been related to conduction disturbances in the
heart of alloxan-induced diabetic rabbits [34]. However, we
found no difference in Na+-channel activity between
FFFRs and controls in isolated ventricular cardiomyo-
cytes. Cell capacitance was also unchanged between
groups, suggesting that the altered conduction velocity
in FFFRs cannot be explained by a difference in cell size
or Na+-channel activity.
Excitation is opposed by the hyperpolarizing action of
IK1, which in principle could slow conduction, but no
differences were observed between groups, excluding
this possibility. On the other hand, several studies have
shown that K+ currents, especially the transient outward
K+ current (Ito) is related to repolarization abnormalities
in diabetes (reviewed in [35]) and may lead to increased
risk of arrhythmia. Therefore, we also evaluated the K+
currents in cardiomyocytes from FFFRs and control rats,
however, as for the Na+ currents, no significant differ-
ences were observed.
In addition to changes in gap junction coupling and
the excitability of the individual cells, another parameter,
which may affect conduction velocity in cardiac tissue, is
electrical obstacles such as fibrosis (Reviewed in [36]).
However, neither the FFFRs used in this study nor the
ZDF rats, which were previously reported to have de-
creased conduction velocity [11], have any detectable in-
crease in fibrosis (Fig. 6). Another parameter which is,
however, found to be altered in both the FFFR and the
ZDF model, is the marked intramyocardial lipid accumu-
lation. Lipotoxicity due to ectopic lipid accumulation is
a well-known phenomenon in diabetic cardiomyopathy
(reviewed by [37]). Lipotoxicity has been connected to
changes in cardiac energy status and lipoapoptosis [37],
as well as development of altered cardiac signaling and
mitochondrial remodeling [38]. Using a model study, it
has been shown that altered mitochondrial function may
contribute to the development of an arrhythmogenic sub-
strate in the heart, but very little is known about its effects
on the electrophysiological properties of the heart. Based
on these observations, cardiac lipid accumulation and its
effect on cardiac signaling and mitochondrial function be-
comes interesting topics for future electrophysiological
studies and may potentially contribute to the conduction
disturbances seen in the FFFR model.
Another pro-arrhythmia mechanism, which remains
unexplored in this study, is remodeling of the autonomic
nervous system. Adrenoreceptor stimulation is found to
Axelsen et al. Cardiovascular Diabetology  (2015) 14:87 Page 13 of 14trigger arrhythmias originating in the sinoatrial node of
diabetic db/db mice [39] and remodeling of the auto-
nomic nervous system may conspire to increase cardiac
mortality in diabetic patients.
Conclusion
With the data presented in this paper we demonstrate that
FFFRs have QRS prolongation in vivo, as well as decreased
conduction velocity ex vivo. One FFFR showed frequent
PVCs under unstressed conditions in vivo and isolated
hearts from FFFRs had increased susceptibility to VF fol-
lowing cardiac ischemia-reperfusion. At the same time, we
found no alterations in gap junctional coupling, Na+ or K+
current density, cell size, or fibrosis. This shows that the
mechanism of conductance disturbances in the pre-diabetic
heart differs from the mechanisms seen in cardiac ischemia
and heart failure. Further studies are therefore needed in
order to determine the pro-arrhythmic role of specific pre-
diabetic related complications such as intramyocardial lipid
accumulation, mitochondrial dysfunction, altered cardiac
signaling and metabolism. Increased knowledge of the pro-
arrhythmic mechanism in pre-diabetic and diabetic hearts
remains important to improve the anti-arrhythmic treat-
ment of diabetic patients and to decrease the risk of sudden
cardiac death in diabetes.Abbreviations
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